EPISODE · Feb 5, 2021 · 11 MIN
MPR Weekly Dose #67 - Efficacy data for AstraZeneca, J&J and Novovax vaccines; Approvals in analgesia and influenza.
from MPR Weekly Dose
This week we take a look at the remaining prospective COVID vaccines, that includes AstraZeneca, J&J and Novovax; There's also drug approvals for analgesia and influenza.
Embed this episode
Ready to play
MPR Weekly Dose #67 - Efficacy data for AstraZeneca, J&J and Novovax vaccines; Approvals in analgesia and influenza.
0:00
11:59
1×
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.
Frequently Asked Questions
How long is this episode of MPR Weekly Dose?
This episode is 11 minutes long.
When was this MPR Weekly Dose episode published?
This episode was published on February 5, 2021.
Can I download this MPR Weekly Dose episode?
Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!